通过血液警戒确保安全输血做法:印度与全球形势的对比。

IF 1.1 Q4 PHARMACOLOGY & PHARMACY
Ruhi Rana, Sastha Ram Veluri Kishore, Gagandeep Kaur, Gurvinder Singh, Rajesh Kumar
{"title":"通过血液警戒确保安全输血做法:印度与全球形势的对比。","authors":"Ruhi Rana,&nbsp;Sastha Ram Veluri Kishore,&nbsp;Gagandeep Kaur,&nbsp;Gurvinder Singh,&nbsp;Rajesh Kumar","doi":"10.2174/1574886318666221206114638","DOIUrl":null,"url":null,"abstract":"<p><p>Haemovigilance is the monitoring of the essential components of blood transfusion from its initial stages to the final outcome considering all the safety parameters and hazards that co-exist with it. It primarily aims to ensure the quality as well as safety related to the use of blood and blood products utilizing the standard healthcare framework and a tailored vigilance program for efficient outcomes. Initially, the art of vigilance was started with the therapeutic products available in the market giving some groundbreaking data on their safety which later led to the implementation of timely measures to control adverse events significantly. Several incidents have occurred during the collection, transport, storage, and transfusion of blood and to stop these incidences of hazard, haemovigilance came into existence with France becoming the first country to step in followed by several nations across the world with customized guidelines directing it to the best. The majorly reported problems include bacterial infections, hemolytic and immune reactions. The present writeup reviews the inception and development of haemovigilance programs with a global scenario, a detailed study of the haemovigilance program adopted in India, and the updated status of these programs in various countries across the globe.</p>","PeriodicalId":10777,"journal":{"name":"Current drug safety","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ensuring Safe Transfusion Practices through Haemovigilance: India <i>vis-a-vis</i> Global Scenario.\",\"authors\":\"Ruhi Rana,&nbsp;Sastha Ram Veluri Kishore,&nbsp;Gagandeep Kaur,&nbsp;Gurvinder Singh,&nbsp;Rajesh Kumar\",\"doi\":\"10.2174/1574886318666221206114638\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Haemovigilance is the monitoring of the essential components of blood transfusion from its initial stages to the final outcome considering all the safety parameters and hazards that co-exist with it. It primarily aims to ensure the quality as well as safety related to the use of blood and blood products utilizing the standard healthcare framework and a tailored vigilance program for efficient outcomes. Initially, the art of vigilance was started with the therapeutic products available in the market giving some groundbreaking data on their safety which later led to the implementation of timely measures to control adverse events significantly. Several incidents have occurred during the collection, transport, storage, and transfusion of blood and to stop these incidences of hazard, haemovigilance came into existence with France becoming the first country to step in followed by several nations across the world with customized guidelines directing it to the best. The majorly reported problems include bacterial infections, hemolytic and immune reactions. The present writeup reviews the inception and development of haemovigilance programs with a global scenario, a detailed study of the haemovigilance program adopted in India, and the updated status of these programs in various countries across the globe.</p>\",\"PeriodicalId\":10777,\"journal\":{\"name\":\"Current drug safety\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current drug safety\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1574886318666221206114638\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574886318666221206114638","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

血液警戒是在考虑所有安全参数和与之共存的危险的情况下,从输血的初始阶段到最终结果对输血的基本成分进行监测。它的主要目的是确保与使用血液和血液制品相关的质量和安全,利用标准的医疗保健框架和量身定制的警戒计划,以获得有效的结果。最初,警惕的艺术是从市场上可用的治疗产品开始的,这些产品提供了一些关于其安全性的开创性数据,后来导致及时采取措施,显著控制不良事件。在收集、运输、储存和输血过程中发生了几起事故,为了阻止这些危险事件的发生,血液警戒应运而生,法国是第一个介入的国家,随后世界上几个国家也制定了定制的指导方针,将其引向最佳状态。主要报道的问题包括细菌感染、溶血和免疫反应。本文回顾了血液警戒项目在全球范围内的开始和发展,对印度采用的血液警戒项目进行了详细研究,并介绍了这些项目在全球不同国家的最新状况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Ensuring Safe Transfusion Practices through Haemovigilance: India vis-a-vis Global Scenario.

Haemovigilance is the monitoring of the essential components of blood transfusion from its initial stages to the final outcome considering all the safety parameters and hazards that co-exist with it. It primarily aims to ensure the quality as well as safety related to the use of blood and blood products utilizing the standard healthcare framework and a tailored vigilance program for efficient outcomes. Initially, the art of vigilance was started with the therapeutic products available in the market giving some groundbreaking data on their safety which later led to the implementation of timely measures to control adverse events significantly. Several incidents have occurred during the collection, transport, storage, and transfusion of blood and to stop these incidences of hazard, haemovigilance came into existence with France becoming the first country to step in followed by several nations across the world with customized guidelines directing it to the best. The majorly reported problems include bacterial infections, hemolytic and immune reactions. The present writeup reviews the inception and development of haemovigilance programs with a global scenario, a detailed study of the haemovigilance program adopted in India, and the updated status of these programs in various countries across the globe.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current drug safety
Current drug safety PHARMACOLOGY & PHARMACY-
CiteScore
2.10
自引率
0.00%
发文量
112
期刊介绍: Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信